Skip to content
Business
Future of British Business

AstraZeneca Sues to Block Top Dealmaker Sharing Therapy Data With GSK

  • GSK poached Chris Sheldon to boost its drug pipelines
  • AstraZeneca says Sheldon could breach non-compete agreement
GSK headquarters in the Brentford district of London.

GSK headquarters in the Brentford district of London.

Photographer: Chris Ratcliffe/Bloomberg

AstraZeneca Plc sued in London to block a former top dealmaker from sharing key therapy information with his new employer GSK Plc, saying Chris Sheldon was in danger of breaching a non-compete agreement. 

Sheldon, who was one of AstraZeneca’s most senior employees, is set to start at GSK in September. The executive had access to confidential information in a whole host of sensitive areas including the firm’s cancer work, AstraZeneca said in a legal filing. He was paid more than £644,000 ($774,090) in shares in 2021 to sign the non-compete clause.